SynthesisPloS one2024
Essential and toxic metal concentrations in biological samples of multiple sclerosis patients: A systematic review and meta-analysis.
Synthesis in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigation of the Relationship Between Serum Trace Elements and MSFC Levels in Multiple Sclerosis: A Cross-sectional Case-Control Study.Biological trace element research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of trace elements and toxic metals on human health has been extensively discussed concerning disease pathogenesis and risk factors of diseases. In this systematic review and meta-analysis, we aimed to investigate arsenic (As), cadmium (Cd), lead (Pb), iron (Fe), zinc (Zn), and magnesium (Mg) levels in individuals with multiple sclerosis (MS) and healthy controls. We searched different databases/search engines for this systematic review and meta-analysis, including Web of Science, PubMed, Scopus, and Google Scholar, until June 27, 2024. Out of 5466 studies identified, 65 met our eligibility criteria and were included in the systematic review. For the meta-analysis, 58 studies with 10420 participants (5316 multiple sclerosis patients and 5104 healthy controls) had adequate data for inclusion. Results from the pooled data, analyzed using a random-effects model, revealed higher levels of As (Hedge's g = 4.00 μg/l, 95% CI = 2.03 to 5.98, P <0.001; I2 = 97.69%, P<0.001) and Cd (Hedge's g = 1.20 μg/l, 95% CI = 0.13 to 2.27, P = 0.028; I2 = 97.99%, P<0.001) in multiple sclerosis patients compared to healthy ones. However, no significant differences were observed in the concentrations of Zn, Fe, Mg, and Pb between the two groups. This study identified elevated As and Cd levels in MS patients, indicating the need for targeted interventions and public health guidelines for toxic metal exposure. Limiting exposure to contaminated environments and maintaining essential element levels through natural resources or supplements is essential, as there may be a possible relationship between multiple sclerosis and the concentrations of these elements in humans.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.